Ranq Pharmaceuticals And Excipients Private Limited - Company Profile

It is a pharma private limited company based in Thane, Maharashtra, India, established in 1991.
1991 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Ranq Pharmaceuticals And Excipients Private Limited

Ranq Pharmaceuticals And Excipients Private Limited, a active private limited company, was established on 02 August 1991 in Thane, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1991PTC062793. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹1.33 M.

It upholds a compliant status. Its leadership includes Sameer Gajanan Ranadive (Director), Janhavi Bhargav Jangle (Director). Past directors included Hemant Naiknavare Dattaji, Gauri Hemant Naiknavare, Sudha Gajanan Ranadive. It holds ₹8.13 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Gala No.112, 1St Floor, Ganatra Industrial Estate Next To Punjani Estate,Pokharan Road No., 1 Khopat ,, Thane, Maharashtra, 400601.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH1991PTC062793

  • Registration Number

    062793

  • Incorporation Date

    02 August 1991

  • Authorized Capital

    ₹2.00 M

  • Paid-Up Capital

    ₹1.33 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 M
  • Paid Up Capital ₹ 1.33 M
  • Company Age 34 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 8.13 M
  • Revenue Growth **** -44.55%
  • Profit Growth **** -79.02%
  • Ebitda **** 4.26%
  • Net Worth 0.26%
  • Total Assets **** 1.11%
Company report

Ranq Pharmaceuticals And Excipients Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ranq Pharmaceuticals And Excipients Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ranq Pharmaceuticals And Excipients Private Limited?
Current Directors
Name Designation Appointment Date Status
Sameer Gajanan Ranadive Director 02 Aug 1991 Current
Janhavi Bhargav Jangle Director 18 Jul 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Dec 2013 Past
Pramod Abcsdd Director 01 Jul 2014 Past
Pramod Abcsdd Director 31 Mar 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ranq Pharmaceuticals And Excipients.

Ranq Pharmaceuticals And Excipients Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 44.55% decrease. The company also saw a substantial fall in profitability, with a 79.02% decrease in profit. The company's net worth moved up by a moderate rise of 0.26%.

Ranq Pharmaceuticals And Excipients revenue growth over time
Ranq Pharmaceuticals And Excipients profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -44.55%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 1.11%
*******
*******
*******
*******
Profit or Loss
*******
 -79.02%
*******
*******
*******
*******
Net Worth
*******
 0.26%
*******
*******
*******
*******
EBITDA
*******
 4.26%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ranq Pharmaceuticals And Excipients?

In 2023, Ranq Pharmaceuticals And Excipients had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹8,125,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • The Maharashtra State Financial Corpn. : 0.58 Cr
  • Bank Of Baroda : 0.23 Cr
Latest Charge Details
Date Lender Amount Status
16 Aug 1995 Bank Of Baroda ₹1.60 M Open
02 Jun 1995 Bank Of Baroda ₹0.73 M Open
02 Jan 1992 The Maharashtra State Financial Corpn. ₹5.80 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Ranq Pharmaceuticals And Excipients?

Ranq Pharmaceuticals And Excipients has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ranq Pharmaceuticals And Excipients, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ranq Pharmaceuticals And Excipients's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ranq Pharmaceuticals And Excipients
Recent Activity within the Organization
  • Annual General Meeting

    Ranq Pharmaceuticals And Excipients Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Ranq Pharmaceuticals And Excipients Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    Progress on Janhavi Bhargav Jangle was appointed as a Director was appointed as a Director on 18 Jul 2013 & has been associated with this company since 12 years 7 months . was documented.

  • Charges

    Progress on A charge with Bank Of Baroda amounted to Rs. 1.60 M with Charge ID 90153178 was registered on 16 Aug 1995. was documented.

  • Charges

    Progress on A charge with Bank Of Baroda amounted to Rs. 0.73 M with Charge ID 90153144 was registered on 02 Jun 1995. was documented.

  • Charges

    The activity A charge with Bank Of Baroda of Rs. 0.73 M registered on 02 Jun 1995 with Charge ID 90153144 was modified on 02 Jun 1995. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ranq Pharmaceuticals And Excipients Private Limited?

The CIN of Ranq Pharmaceuticals And Excipients Private Limited is U24230MH1991PTC062793.

Where is Ranq Pharmaceuticals And Excipients Private Limited headquartered?

Ranq Pharmaceuticals And Excipients Private Limited is headquartered at Gala No.112, 1St Floor, Ganatra Industrial Estate Next To Punjani Estate,Pokharan Road No., 1 Khopat ,, Thane, Maharashtra, 400601.

When was Ranq Pharmaceuticals And Excipients Private Limited incorporated?

Ranq Pharmaceuticals And Excipients Private Limited was incorporated on 02 August 1991.

Who are the current directors of Ranq Pharmaceuticals And Excipients Private Limited?

The current directors of Ranq Pharmaceuticals And Excipients Private Limited are

What is the primary industry of Ranq Pharmaceuticals And Excipients Private Limited?

The primary industry of Ranq Pharmaceuticals And Excipients Private Limited is Manufacturing.

Is Ranq Pharmaceuticals And Excipients Private Limited a listed company?

Ranq Pharmaceuticals And Excipients Private Limited is unlisted.

What is the capital structure of Ranq Pharmaceuticals And Excipients Private Limited?

The authorized capital of Ranq Pharmaceuticals And Excipients Private Limited is ₹2.00 M, and the paid-up capital is ₹1.33 M.

What is the compliance status of Ranq Pharmaceuticals And Excipients Private Limited?

The compliance status of Ranq Pharmaceuticals And Excipients Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available